🔴 Outlook Therapeutics is trading 7.7% down today as it extends a pullback from its recent FDA-driven rally

Outlook Therapeutics is trading at $0.90 (-7.65%) today as the stock extends a pullback from its late-July surge.

• The decline is primarily driven by profit-taking and consolidation following a significant rally triggered by recent FDA approval news.
• Shares are continuing to retreat after failing to sustain momentum from gains seen on July 29 and July 30.
• The downward move appears to be company-specific, as broader market indices are currently trading higher.